RxDoctor Payments Data

Lucio Martinez, MD

Family Medicine · Rockford, ILNPI 1154397354

Payments from drug & device makers

$397in general payments, 2019–2025

Across 26 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$76
  • AstraZeneca$52
  • Novo Nordisk$44
  • Kowa Pharmaceuticals America, Inc.$40
  • Amgen$35
  • GSK$32
  • plus $118 from 7 others

What the payments were for

  • Food & beverage$397100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$397 in reported general payments places this provider in the 60th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$50,733
Medicare patients
173
Services billed
735

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin109$137,285
XareltoRivaroxaban98$108,809
EliquisApixaban60$60,470
OzempicSemaglutide50$52,195
TrulicityDulaglutide23$41,578
TradjentaLinagliptin33$38,312
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog63$36,932
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$30,289
JanuviaSitagliptin Phosphate18$18,166
Spiriva HandihalerTiotropium Bromide16$17,305
MyrbetriqMirabegron13$13,108
EntrestoSacubitril/Valsartan14$12,656
Breo ElliptaFluticasone/Vilanterol30$11,988
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$6,798
Combivent RespimatIpratropium/Albuterol Sulfate13$6,323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$11$108,80998 claims
Novo NordiskOzempic$44$52,19550 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$32$46,14186 claims
Lilly USA, LLCTrulicity$76$41,57823 claims
Astellas Pharma US IncMyrbetriq$30$13,10813 claims
Sanofi-aventis U.S. LLCLantus$15$2,53318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Rockford

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →